Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polychlorinated Biphenyls | 8 | 2016 | 147 | 2.880 |
Why?
|
| Environmental Pollutants | 7 | 2019 | 180 | 2.430 |
Why?
|
| Diabetic Nephropathies | 6 | 2017 | 161 | 2.350 |
Why?
|
| Dioxins | 5 | 2016 | 15 | 2.190 |
Why?
|
| Nutrition Surveys | 22 | 2019 | 208 | 2.030 |
Why?
|
| DDT | 4 | 2019 | 19 | 1.990 |
Why?
|
| Furans | 4 | 2016 | 27 | 1.880 |
Why?
|
| Diabetes Mellitus | 13 | 2019 | 694 | 1.880 |
Why?
|
| Environmental Exposure | 4 | 2019 | 269 | 1.400 |
Why?
|
| Life Style | 9 | 2012 | 338 | 1.180 |
Why?
|
| Hypertension | 12 | 2010 | 1535 | 1.050 |
Why?
|
| C-Reactive Protein | 4 | 2011 | 180 | 0.980 |
Why?
|
| Prediabetic State | 2 | 2016 | 48 | 0.920 |
Why?
|
| Pesticides | 2 | 2017 | 41 | 0.900 |
Why?
|
| United States | 37 | 2019 | 7367 | 0.880 |
Why?
|
| Vitamin D Deficiency | 3 | 2010 | 292 | 0.860 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2017 | 1085 | 0.800 |
Why?
|
| Adult | 52 | 2019 | 21403 | 0.780 |
Why?
|
| Middle Aged | 57 | 2018 | 21147 | 0.780 |
Why?
|
| Logistic Models | 16 | 2019 | 1420 | 0.760 |
Why?
|
| Cardiovascular Diseases | 7 | 2011 | 940 | 0.740 |
Why?
|
| Mexican Americans | 2 | 2019 | 30 | 0.730 |
Why?
|
| Aged | 43 | 2018 | 14862 | 0.700 |
Why?
|
| Male | 62 | 2019 | 37321 | 0.680 |
Why?
|
| Coronary Disease | 6 | 2010 | 358 | 0.680 |
Why?
|
| Odds Ratio | 10 | 2019 | 880 | 0.650 |
Why?
|
| Female | 59 | 2019 | 38074 | 0.630 |
Why?
|
| Humans | 73 | 2019 | 68618 | 0.610 |
Why?
|
| Arginine | 2 | 2011 | 102 | 0.610 |
Why?
|
| Risk Factors | 25 | 2012 | 5731 | 0.600 |
Why?
|
| Albuminuria | 2 | 2016 | 171 | 0.580 |
Why?
|
| Insulin Resistance | 2 | 2010 | 241 | 0.560 |
Why?
|
| Health Surveys | 11 | 2012 | 489 | 0.540 |
Why?
|
| Carrier State | 3 | 2011 | 39 | 0.510 |
Why?
|
| Heptachlor Epoxide | 1 | 2015 | 2 | 0.500 |
Why?
|
| Cholesterol, LDL | 3 | 2011 | 161 | 0.490 |
Why?
|
| Body Mass Index | 10 | 2012 | 867 | 0.490 |
Why?
|
| Insecticides | 1 | 2015 | 43 | 0.490 |
Why?
|
| Mortality | 3 | 2018 | 163 | 0.480 |
Why?
|
| Nasal Cavity | 3 | 2011 | 62 | 0.450 |
Why?
|
| Young Adult | 15 | 2017 | 5717 | 0.450 |
Why?
|
| Kidney Diseases | 1 | 2016 | 307 | 0.440 |
Why?
|
| Hypoglycemic Agents | 3 | 2011 | 362 | 0.440 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2011 | 92 | 0.430 |
Why?
|
| Staphylococcal Infections | 2 | 2011 | 156 | 0.410 |
Why?
|
| Health Behavior | 4 | 2010 | 458 | 0.410 |
Why?
|
| Biomarkers | 5 | 2011 | 1593 | 0.390 |
Why?
|
| Insulin | 3 | 2010 | 619 | 0.390 |
Why?
|
| Blood Pressure | 6 | 2011 | 1451 | 0.380 |
Why?
|
| Risk Reduction Behavior | 2 | 2012 | 174 | 0.380 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 77 | 0.380 |
Why?
|
| Cross-Sectional Studies | 11 | 2012 | 2279 | 0.360 |
Why?
|
| Food Labeling | 1 | 2010 | 10 | 0.360 |
Why?
|
| Overweight | 1 | 2012 | 186 | 0.360 |
Why?
|
| Alcohol Drinking | 4 | 2011 | 805 | 0.350 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2010 | 38 | 0.350 |
Why?
|
| Proportional Hazards Models | 8 | 2018 | 792 | 0.350 |
Why?
|
| Smoking | 8 | 2012 | 1452 | 0.340 |
Why?
|
| Cohort Studies | 10 | 2011 | 2358 | 0.330 |
Why?
|
| Hyperlipidemias | 2 | 2010 | 90 | 0.330 |
Why?
|
| Transferrin | 3 | 2011 | 94 | 0.320 |
Why?
|
| Choice Behavior | 1 | 2009 | 85 | 0.320 |
Why?
|
| Obesity | 4 | 2012 | 1076 | 0.320 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2008 | 22 | 0.310 |
Why?
|
| Cadmium | 1 | 2007 | 21 | 0.300 |
Why?
|
| Lipids | 2 | 2006 | 298 | 0.300 |
Why?
|
| Neoplasms | 4 | 2007 | 1667 | 0.300 |
Why?
|
| Coronary Artery Disease | 5 | 2012 | 696 | 0.290 |
Why?
|
| Oxidative Stress | 1 | 2011 | 718 | 0.290 |
Why?
|
| Fibrinogen | 1 | 2007 | 87 | 0.280 |
Why?
|
| Diabetic Neuropathies | 1 | 2006 | 33 | 0.280 |
Why?
|
| Patient Compliance | 1 | 2009 | 402 | 0.280 |
Why?
|
| Adolescent | 12 | 2017 | 8912 | 0.270 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2006 | 10 | 0.270 |
Why?
|
| Erectile Dysfunction | 1 | 2006 | 22 | 0.270 |
Why?
|
| Health Status Disparities | 1 | 2009 | 326 | 0.270 |
Why?
|
| Leukocytes | 3 | 2010 | 99 | 0.260 |
Why?
|
| Telomere | 3 | 2010 | 59 | 0.260 |
Why?
|
| Hospitalization | 4 | 2018 | 978 | 0.260 |
Why?
|
| Magnesium | 1 | 2006 | 110 | 0.260 |
Why?
|
| Risk Assessment | 8 | 2012 | 2007 | 0.250 |
Why?
|
| Iron, Dietary | 1 | 2005 | 6 | 0.250 |
Why?
|
| Chronic Disease | 1 | 2010 | 1330 | 0.250 |
Why?
|
| Vasodilator Agents | 1 | 2006 | 138 | 0.250 |
Why?
|
| Piperazines | 1 | 2006 | 206 | 0.240 |
Why?
|
| Heart Failure | 3 | 2018 | 1180 | 0.240 |
Why?
|
| Quality of Health Care | 1 | 2007 | 322 | 0.240 |
Why?
|
| Population Surveillance | 1 | 2005 | 285 | 0.220 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2011 | 504 | 0.220 |
Why?
|
| Body Weight | 1 | 2005 | 554 | 0.220 |
Why?
|
| Emergency Service, Hospital | 3 | 2018 | 711 | 0.220 |
Why?
|
| Primary Health Care | 5 | 2011 | 703 | 0.210 |
Why?
|
| Delivery of Health Care | 2 | 2018 | 445 | 0.210 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 807 | 0.210 |
Why?
|
| Age Factors | 6 | 2009 | 1864 | 0.200 |
Why?
|
| Iron Overload | 2 | 2011 | 28 | 0.190 |
Why?
|
| Child | 5 | 2017 | 6405 | 0.190 |
Why?
|
| Chi-Square Distribution | 3 | 2010 | 546 | 0.180 |
Why?
|
| Cholesterol | 3 | 2006 | 331 | 0.180 |
Why?
|
| Prospective Studies | 4 | 2012 | 3705 | 0.170 |
Why?
|
| ROC Curve | 4 | 2008 | 392 | 0.170 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2018 | 307 | 0.170 |
Why?
|
| Causality | 2 | 2010 | 82 | 0.160 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2019 | 25 | 0.160 |
Why?
|
| Urban Population | 2 | 2018 | 255 | 0.160 |
Why?
|
| Episode of Care | 1 | 2018 | 12 | 0.160 |
Why?
|
| Feeding Behavior | 2 | 2011 | 224 | 0.160 |
Why?
|
| Patient Education as Topic | 3 | 2012 | 425 | 0.150 |
Why?
|
| Nonprescription Drugs | 2 | 2010 | 28 | 0.150 |
Why?
|
| Health Services | 1 | 2018 | 87 | 0.150 |
Why?
|
| Sensitivity and Specificity | 4 | 2011 | 1753 | 0.150 |
Why?
|
| Confidence Intervals | 3 | 2008 | 242 | 0.150 |
Why?
|
| Blood Glucose | 3 | 2008 | 631 | 0.140 |
Why?
|
| Rural Population | 2 | 2018 | 398 | 0.140 |
Why?
|
| Health Services Accessibility | 4 | 2010 | 581 | 0.140 |
Why?
|
| Health Status Indicators | 2 | 2007 | 117 | 0.140 |
Why?
|
| Sex Factors | 3 | 2008 | 1266 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 3 | 2009 | 1026 | 0.130 |
Why?
|
| Iron | 3 | 2011 | 197 | 0.130 |
Why?
|
| Follow-Up Studies | 5 | 2010 | 3259 | 0.130 |
Why?
|
| Hemochromatosis | 2 | 2012 | 13 | 0.130 |
Why?
|
| Socioeconomic Factors | 3 | 2007 | 955 | 0.130 |
Why?
|
| Stroke | 1 | 2008 | 2163 | 0.130 |
Why?
|
| Cholesterol, HDL | 2 | 2006 | 112 | 0.130 |
Why?
|
| Hospitals, Veterans | 1 | 2015 | 147 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 772 | 0.120 |
Why?
|
| Disabled Persons | 1 | 2015 | 94 | 0.120 |
Why?
|
| Exercise | 3 | 2011 | 658 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2008 | 1465 | 0.120 |
Why?
|
| Hospital Mortality | 2 | 2015 | 384 | 0.110 |
Why?
|
| Chlamydophila Infections | 1 | 2012 | 6 | 0.110 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2012 | 13 | 0.110 |
Why?
|
| Ferritins | 3 | 2011 | 49 | 0.110 |
Why?
|
| Hospitals, Religious | 1 | 2011 | 4 | 0.100 |
Why?
|
| Hospitals, Proprietary | 1 | 2011 | 4 | 0.100 |
Why?
|
| Calcinosis | 2 | 2010 | 241 | 0.100 |
Why?
|
| Aged, 80 and over | 6 | 2012 | 4848 | 0.100 |
Why?
|
| Fasting | 2 | 2008 | 75 | 0.100 |
Why?
|
| Health Status | 3 | 2010 | 429 | 0.100 |
Why?
|
| Hospitals, Public | 1 | 2011 | 22 | 0.100 |
Why?
|
| Time Factors | 5 | 2012 | 4655 | 0.100 |
Why?
|
| F2-Isoprostanes | 1 | 2011 | 14 | 0.100 |
Why?
|
| Coffee | 1 | 2011 | 18 | 0.100 |
Why?
|
| Drug Prescriptions | 2 | 2010 | 135 | 0.100 |
Why?
|
| Dinoprost | 1 | 2011 | 27 | 0.100 |
Why?
|
| Tea | 1 | 2011 | 23 | 0.100 |
Why?
|
| Nitrites | 1 | 2011 | 53 | 0.100 |
Why?
|
| Nitrates | 1 | 2011 | 61 | 0.100 |
Why?
|
| Uric Acid | 1 | 2011 | 37 | 0.100 |
Why?
|
| Vascular Calcification | 1 | 2012 | 131 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 1046 | 0.090 |
Why?
|
| Diet | 2 | 2011 | 514 | 0.090 |
Why?
|
| Medicare Part D | 1 | 2010 | 5 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2011 | 260 | 0.090 |
Why?
|
| Marital Status | 1 | 2010 | 65 | 0.090 |
Why?
|
| Electronic Health Records | 2 | 2011 | 374 | 0.090 |
Why?
|
| Incidence | 3 | 2010 | 1603 | 0.090 |
Why?
|
| Comorbidity | 3 | 2012 | 1426 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2011 | 107 | 0.090 |
Why?
|
| Serum | 1 | 2010 | 24 | 0.090 |
Why?
|
| Patients | 1 | 2010 | 69 | 0.090 |
Why?
|
| Drug Costs | 1 | 2010 | 87 | 0.090 |
Why?
|
| Reference Standards | 1 | 2010 | 115 | 0.090 |
Why?
|
| Simvastatin | 1 | 2010 | 34 | 0.090 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2011 | 88 | 0.090 |
Why?
|
| Self Medication | 2 | 2009 | 25 | 0.080 |
Why?
|
| Gastrointestinal Agents | 1 | 2010 | 51 | 0.080 |
Why?
|
| Drug Therapy | 1 | 2009 | 71 | 0.080 |
Why?
|
| Anticholesteremic Agents | 1 | 2009 | 49 | 0.080 |
Why?
|
| South Carolina | 3 | 2011 | 2752 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 281 | 0.080 |
Why?
|
| Blood Pressure Determination | 1 | 2010 | 152 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2005 | 714 | 0.080 |
Why?
|
| Commerce | 1 | 2009 | 80 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1851 | 0.080 |
Why?
|
| Hepatitis B Antibodies | 1 | 2008 | 8 | 0.080 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 130 | 0.080 |
Why?
|
| Glucose Tolerance Test | 1 | 2008 | 75 | 0.080 |
Why?
|
| Hepatitis C Antibodies | 1 | 2008 | 19 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2011 | 3187 | 0.080 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 136 | 0.080 |
Why?
|
| Reference Values | 1 | 2010 | 579 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2009 | 219 | 0.080 |
Why?
|
| Aspartate Aminotransferases | 1 | 2008 | 87 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 240 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2010 | 206 | 0.080 |
Why?
|
| Prescription Drugs | 1 | 2009 | 71 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2008 | 59 | 0.080 |
Why?
|
| Energy Intake | 2 | 2010 | 123 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2011 | 287 | 0.080 |
Why?
|
| Alanine Transaminase | 1 | 2008 | 137 | 0.080 |
Why?
|
| Length of Stay | 1 | 2011 | 780 | 0.080 |
Why?
|
| Veterans | 1 | 2015 | 904 | 0.080 |
Why?
|
| Medical Records | 1 | 2008 | 121 | 0.080 |
Why?
|
| Health Policy | 1 | 2010 | 221 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 212 | 0.080 |
Why?
|
| Prognosis | 3 | 2012 | 2093 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2018 | 7277 | 0.070 |
Why?
|
| Aging | 2 | 2010 | 911 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 2009 | 319 | 0.070 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2007 | 15 | 0.070 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 318 | 0.070 |
Why?
|
| Creatinine | 1 | 2007 | 243 | 0.070 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2007 | 73 | 0.070 |
Why?
|
| Diabetic Foot | 1 | 2007 | 33 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2008 | 158 | 0.070 |
Why?
|
| Apolipoproteins B | 1 | 2006 | 29 | 0.070 |
Why?
|
| Self-Assessment | 1 | 2007 | 69 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2011 | 413 | 0.070 |
Why?
|
| Bronchitis | 1 | 2006 | 8 | 0.070 |
Why?
|
| Internet | 1 | 2009 | 390 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2008 | 1342 | 0.070 |
Why?
|
| Diabetic Retinopathy | 1 | 2007 | 110 | 0.070 |
Why?
|
| Sensation | 1 | 2006 | 49 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 529 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 1 | 2007 | 136 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2010 | 1054 | 0.070 |
Why?
|
| Infant | 2 | 2010 | 2891 | 0.070 |
Why?
|
| Sildenafil Citrate | 1 | 2006 | 23 | 0.070 |
Why?
|
| Purines | 1 | 2006 | 39 | 0.070 |
Why?
|
| Cough | 1 | 2006 | 65 | 0.070 |
Why?
|
| Sulfones | 1 | 2006 | 45 | 0.070 |
Why?
|
| Acculturation | 1 | 2006 | 25 | 0.070 |
Why?
|
| Urology | 1 | 2006 | 31 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 45 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 183 | 0.070 |
Why?
|
| Vitamin D | 1 | 2010 | 516 | 0.070 |
Why?
|
| Homeostasis | 1 | 2007 | 291 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2009 | 498 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 202 | 0.060 |
Why?
|
| Prevalence | 2 | 2006 | 1619 | 0.060 |
Why?
|
| Language | 1 | 2006 | 120 | 0.060 |
Why?
|
| Dietary Fiber | 1 | 2005 | 37 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2006 | 239 | 0.060 |
Why?
|
| Internal Medicine | 1 | 2006 | 118 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 175 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1040 | 0.060 |
Why?
|
| Mental Recall | 1 | 2005 | 72 | 0.060 |
Why?
|
| Self Care | 1 | 2007 | 253 | 0.060 |
Why?
|
| Asthma | 1 | 2008 | 345 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 767 | 0.060 |
Why?
|
| Heart Rate | 1 | 2006 | 568 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 786 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2018 | 468 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2006 | 622 | 0.060 |
Why?
|
| Inflammation | 1 | 2010 | 1030 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2010 | 824 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 567 | 0.060 |
Why?
|
| Ambulatory Care | 3 | 2011 | 340 | 0.060 |
Why?
|
| Family Practice | 1 | 2006 | 312 | 0.050 |
Why?
|
| Dementia | 1 | 2005 | 158 | 0.050 |
Why?
|
| Disease Progression | 2 | 2018 | 1038 | 0.050 |
Why?
|
| Acute Disease | 2 | 2018 | 658 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 565 | 0.040 |
Why?
|
| Liver Function Tests | 2 | 2011 | 114 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7029 | 0.040 |
Why?
|
| Hypercholesterolemia | 2 | 2009 | 86 | 0.040 |
Why?
|
| United Kingdom | 2 | 2010 | 152 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2008 | 274 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2018 | 252 | 0.030 |
Why?
|
| Drug Utilization | 2 | 2006 | 119 | 0.030 |
Why?
|
| Diabetes Complications | 2 | 2007 | 249 | 0.030 |
Why?
|
| Animals | 1 | 2010 | 20881 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2015 | 267 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2012 | 90 | 0.030 |
Why?
|
| Insurance, Hospitalization | 1 | 2011 | 6 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 149 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 114 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2012 | 159 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 521 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2011 | 99 | 0.020 |
Why?
|
| Proteinuria | 1 | 2011 | 136 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2011 | 152 | 0.020 |
Why?
|
| Office Visits | 1 | 2011 | 83 | 0.020 |
Why?
|
| Longevity | 1 | 2010 | 60 | 0.020 |
Why?
|
| Pharmacists | 1 | 2011 | 125 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2010 | 99 | 0.020 |
Why?
|
| Medicaid | 1 | 2011 | 302 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 219 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2010 | 180 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 177 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 502 | 0.020 |
Why?
|
| Morbidity | 1 | 2008 | 130 | 0.020 |
Why?
|
| Social Support | 1 | 2010 | 423 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 981 | 0.020 |
Why?
|
| England | 1 | 2006 | 64 | 0.020 |
Why?
|
| Asia, Southeastern | 1 | 2006 | 5 | 0.020 |
Why?
|
| Motor Activity | 1 | 2010 | 621 | 0.020 |
Why?
|
| Liver | 1 | 2011 | 1118 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 91 | 0.020 |
Why?
|
| Mass Screening | 1 | 2011 | 843 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 33 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 349 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 320 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 2004 | 94 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 1196 | 0.010 |
Why?
|
| Triglycerides | 1 | 2004 | 184 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 2800 | 0.010 |
Why?
|